4//SEC Filing
Koenig Sheldon L. 4
Accession 0001628280-23-006991
CIK 0001434868other
Filed
Mar 7, 7:00 PM ET
Accepted
Mar 8, 4:21 PM ET
Size
5.0 KB
Accession
0001628280-23-006991
Insider Transaction Report
Form 4
Koenig Sheldon L.
DirectorPresident and CEO
Transactions
- Sale
Common Stock
2023-03-07$5.06/sh−5,441$27,510→ 194,815 total
Footnotes (2)
- [F1]Shares were sold to satisfy tax obligation on vested shares of performance-based restricted stock units.
- [F2]Consists of 194,815 shares of common stock held, including 1,999 shares recently acquired in Esperion's Employee Stock Purchase Plan.
Documents
Issuer
Esperion Therapeutics, Inc.
CIK 0001434868
Entity typeother
Related Parties
1- filerCIK 0001766524
Filing Metadata
- Form type
- 4
- Filed
- Mar 7, 7:00 PM ET
- Accepted
- Mar 8, 4:21 PM ET
- Size
- 5.0 KB